PharmaSens
PharmaSens is a Swiss company dedicated to simplifying diabetes management through innovative insulin pump technology. They develop a portfolio of insulin patch pumps, including next-generation devices with automated insulin delivery and continuous glucose monitoring, aiming to make insulin therapy more accessible, easier to use, and sustainable.
Industries
Nr. of Employees
small (1-50)
PharmaSens
Aarbergstrasse 46, 2503 Biel/Bienne, Switzerland
Patents
Products
Wearable patch insulin delivery system with optional integrated glucose sensor
Tubeless basal–bolus patch insulin delivery system combining a reusable electronics module with a disposable extended-capacity reservoir; architecture supports wireless connectivity, optional on-patch glucose sensing and integration with closed-loop control algorithms.
Wearable patch insulin delivery system with optional integrated glucose sensor
Tubeless basal–bolus patch insulin delivery system combining a reusable electronics module with a disposable extended-capacity reservoir; architecture supports wireless connectivity, optional on-patch glucose sensing and integration with closed-loop control algorithms.
Services
Collaborative development and engineering partnerships with external technology and manufacturing organizations for integration of patch pump and sensor systems.
Operation and maintenance of a multilingual product catalog and online ordering interface with payment and shipping integrations and affiliate content management.
Collaborative development and engineering partnerships with external technology and manufacturing organizations for integration of patch pump and sensor systems.
Operation and maintenance of a multilingual product catalog and online ordering interface with payment and shipping integrations and affiliate content management.
Expertise Areas
- Wearable insulin delivery systems
- Continuous glucose monitoring integration
- Automated/closed-loop insulin delivery
- Embedded medical device electronics and connectivity
Key Technologies
- Patch wearable insulin pump hardware
- On-patch continuous glucose sensing
- Closed-loop insulin control algorithms
- Combined sensor–infusion insertion mechanisms
News & Updates
PharmaSens and SiBionics enter a strategic partnership to co-develop niia™ signature, a next-generation wearable device that combines insulin delivery with real-time glucose sensing to simplify diabetes management.
Insulin Delivery Innovator PharmaSens Appoints Robert Gabbay, MD and James Peterson to Board of Directors.
PharmaSens has submitted an FDA approval application for its groundbreaking insulin pump system.
PharmaSens has earned ISO 13485 certification and is advancing diabetes care with its niia essential insulin patch pump system.
PharmaSens and SiBionics enter a strategic partnership to co-develop niia™ signature, a next-generation wearable device that combines insulin delivery with real-time glucose sensing to simplify diabetes management.
Insulin Delivery Innovator PharmaSens Appoints Robert Gabbay, MD and James Peterson to Board of Directors.
PharmaSens has submitted an FDA approval application for its groundbreaking insulin pump system.
PharmaSens has earned ISO 13485 certification and is advancing diabetes care with its niia essential insulin patch pump system.